MitoROS™ 580 *Optimized for Detecting Reactive Oxygen Species (ROS) in Mitochondria*
![Fluorescence response of MitoROS™ 580 (10 µM)to different reactive oxygen species (ROS) and reactive nitrogen species (RNS). The fluorescence intensities were monitored at Ex/Em = 540/590 nm.](/_next/image?url=https%3A%2F%2Fimages.aatbio.com%2Fproducts%2Ffigures-and-data%2Fmitoros-580-optimized-for-detecting-reactive-oxygen-species-ros-in-mitochondria%2Ffigure-for-mitoros-580-optimized-for-detecting-reactive-oxygen-species-ros-in-mitochondria_lrlIC.jpg&w=640&q=75)
![Fluorescence response of MitoROS™ 580 (10 µM)to different reactive oxygen species (ROS) and reactive nitrogen species (RNS). The fluorescence intensities were monitored at Ex/Em = 540/590 nm.](/_next/image?url=https%3A%2F%2Fimages.aatbio.com%2Fproducts%2Ffigures-and-data%2Fmitoros-580-optimized-for-detecting-reactive-oxygen-species-ros-in-mitochondria%2Ffigure-for-mitoros-580-optimized-for-detecting-reactive-oxygen-species-ros-in-mitochondria_lrlIC.jpg&w=640&q=75)
![Fluorescence response of MitoROS™ 580 (10 µM)to different reactive oxygen species (ROS) and reactive nitrogen species (RNS). The fluorescence intensities were monitored at Ex/Em = 540/590 nm.](/_next/image?url=https%3A%2F%2Fimages.aatbio.com%2Fproducts%2Ffigures-and-data%2Fmitoros-580-optimized-for-detecting-reactive-oxygen-species-ros-in-mitochondria%2Ffigure-for-mitoros-580-optimized-for-detecting-reactive-oxygen-species-ros-in-mitochondria_lrlIC.jpg&w=128&q=25)
![The detection of intracellular superoxide in Jurkat cells was performed using MitoROS™ 580. For the AMA treatment (Red), cells were treated with 50 µM Antimycin A (AMA) at 37°C for 30 minutes, followed by incubation with MitoROS™ 580 for 1 hour. For the control (Blue), cells were incubated with MitoROS™ 580 at 37°C for 1 hour without prior AMA treatment. The fluorescence signal was monitored using the FL2 channel of a BD FACSCalibur flow cytometer.](/_next/image?url=https%3A%2F%2Fimages.aatbio.com%2Fproducts%2Ffigures-and-data%2Fmitoros-580-optimized-for-detecting-reactive-oxygen-species-ros-in-mitochondria%2Ffigure-for-mitoros-580-optimized-for-detecting-reactive-oxygen-species-ros-in-mitochondria_hiS0f.jpeg&w=128&q=25)
![Fluorescence imaging of superoxide measurement in HeLa cells was performed using MitoROS™ 580. HeLa cells were seeded at a density of 100,000 cells per well in 100 µL and incubated overnight in a 96-well plate with black walls and a clear bottom. For the AMA treatment group, cells were treated with 50 µM Antimycin A (AMA) at 37°C for 30 minutes, followed by incubation with MitoROS™ 580 for 1 hour. In the untreated control group, cells were incubated with MitoROS™ 580 at 37°C for 1 hour without any prior AMA treatment. Fluorescence signals were measured using a fluorescence microscope with a TRITC filter.](/_next/image?url=https%3A%2F%2Fimages.aatbio.com%2Fproducts%2Ffigures-and-data%2Fmitoros-580-optimized-for-detecting-reactive-oxygen-species-ros-in-mitochondria%2Ffigure-for-mitoros-580-optimized-for-detecting-reactive-oxygen-species-ros-in-mitochondria_jMJua.jpeg&w=128&q=25)
![Detection of intracellular superoxide in HeLa Cells using MitoROS™ 580. HeLa cells were seeded at a density of 100,000 cells per well in 100 µL of medium and incubated overnight in a 96-well plate with black walls and a clear bottom. The next day, the cells were treated with either 50 µM Pyocyanin (Pyo), 50 µM Antimycin A (AMA), or left untreated as a control. These treatments were applied at 37°C for 30 minutes. Following this, the cells were incubated with MitoROS™ 580 at 37°C for 1 hour. Fluorescence signals were measured using a CLARIOstar microplate reader (BMG Labtech) with an excitation/emission wavelength of 540/590 nm and a cutoff of 570 nm, using the bottom read mode.](/_next/image?url=https%3A%2F%2Fimages.aatbio.com%2Fproducts%2Ffigures-and-data%2Fmitoros-580-optimized-for-detecting-reactive-oxygen-species-ros-in-mitochondria%2Ffigure-for-mitoros-580-optimized-for-detecting-reactive-oxygen-species-ros-in-mitochondria_VYSVQ.jpeg&w=128&q=25)
PREPARATION OF STOCK SOLUTIONS
Unless otherwise noted, all unused stock solutions should be divided into single-use aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles
Add 13 µL of DMSO to the MitoROS™ 580 vial and mix well.
Note: Any unused stock solution can be stored at -20 °C, protected from light.
PREPARATION OF WORKING SOLUTION
Dilute the DMSO stock solution into Hanks solution with 20 mM Hepes buffer (HHBS) to make a 2X working solution.
Note: The 2X MitoROS™ 580 working solution is not stable, use it promptly.
SAMPLE EXPERIMENTAL PROTOCOL
This protocol is a mere guideline and should be optimized to suit your specific requirements. Prior to making the MitoROS™ 580 working solution, treat cells as desired.
Treat cells as desired.
Incubate the cells (such as 100 µL/well in 96-well plate) with equal volume of 2X MitoROS™ 580 working solution for 10-30 minutes at 37 °C, protected from light.
Note: The final in-cell concentration of the MitoROS™ 580 should not exceed 1X. Higher concentrations can lead to cytotoxic effects, such as altered mitochondrial morphology and fluorescence redistribution to nuclei and cytosol.
Note: Different cells react to MitoROS™ 580 differently, adjust the working concentration accordingly.
Wash cells gently three times and replace it with HHBS buffer.
Analyze the cells with a proper fluorescence instrument (e.g., a fluorescence microscope, flow cytometer) with Ex/Em = 510/580 nm.
Authors: Yang, Liu and Li, Qiao and Wang, Sa and Ji, Yi and Ma, Xinbo and Qin, Ming and Gao, Yanhui and Yang, Yanmei
Journal: Archives of Toxicology (2024): 1--13
Authors: Ji, Yacong and Li, Chongyang and Wan, Sicheng and Dong, Zhen and Liu, Chaolong and Guo, Leiyang and Shi, Shaomin and Ci, Mingxin and Xu, Minghao and Li, Qian and others,
Journal: Journal of Pharmaceutical Analysis (2024): 101036
Authors: Shen, Yu-Xin and Lee, Pe-Shuen and Wang, Chia C and Teng, Ming-Chu and Huang, Jhih-Hong and Fan, Hsiu-Fang
Journal: Chemical Research in Toxicology (2024)
Authors: Tura, Ayseg{\"u}l and Herfs, Viktoria and Maa{\ss}en, Tjorge and Zuo, Huaxin and Vardanyan, Siranush and Prasuhn, Michelle and Ranjbar, Mahdy and Kakkassery, Vinodh and Grisanti, Salvatore
Journal: International Journal of Molecular Sciences (2024): 4292
Authors: Tomomatsu, Manami and Imamura, Naoto and Izumi, Hoshimi and Watanabe, Masatsugu and Ikeda, Masataka and Ide, Tomomi and Uchinomiya, Shohei and Ojida, Akio and Jutanom, Mirinthorn and Morimoto, Kazushi and others,
Journal: Biological and Pharmaceutical Bulletin (2024): 641--651
Authors: Liu R, France B, George S, Rallo R, Zhang H, Xia T, Nel AE, Bradley K, Cohen Y.
Journal: Analyst (2014): 943
Authors: Serrano-Nascimento C, da Silva Teixeira S, Nicola JP, Nachbar RT, Masini-Repiso AM, Nunes MT.
Journal: Endocrinology (2014): 1145
Authors: Kalyanaraman B, Dranka BP, Hardy M, Michalski R, Zielonka J.
Journal: Biochim Biophys Acta (2014): 739
Authors: Hu Z, Yu F, Gong P, Qiu Y, Zhou W, Cui Y, Li J, Chen H.
Journal: Toxicol Appl Pharmacol (2014): 95
Authors: Marques M, Sousa AP, Paiva A, Almeida-Santos T, Ramalho-Santos J.
Journal: Reproduction. (2014)